Unknown

Dataset Information

Rational engineering of adeno-associated virus capsid enhances human hepatocyte tropism and reduces immunogenicity.


ABSTRACT:

Objectives

Gene therapy based on recombinant adeno-associated viral (rAAV) vectors has been proved to be clinically effective for genetic diseases. However, there are still some limitations, including possible safety concerns for high dose delivery and a decreasing number of target patients caused by the high prevalence of pre-existing neutralizing antibodies, hindering its application. Herein, we explored whether there was an engineering strategy that can obtain mutants with enhanced transduction efficiency coupled with reduced immunogenicity.

Methods

We described a new strategy for AAV capsids engineering by combining alterations of N-linked glycosylation and the mutation of PLA2-like motif. With this combined strategy, we generated novel variants derived from AAV8 and AAV

SUBMITTER: Han J 

PROVIDER: S-EPMC9715358 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature